These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8543517)

  • 21. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of lip dyskinesia associated with neuroleptic withdrawal.
    Newell KM; Bodfish JW; Mahorney SL; Sprague RL
    Am J Ment Retard; 2000 Jul; 105(4):260-8. PubMed ID: 10934568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An unrecognised case of withdrawal neuroleptic malignant syndrome: a case report.
    Ball H; de Waal H; Craig K
    Med Sci Law; 2009 Oct; 49(4):298-300. PubMed ID: 20025106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.
    Jeste DV; Lacro JP; Palmer B; Rockwell E; Harris MJ; Caligiuri MP
    Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation of antipsychotic drug therapy.
    Mitchell JE
    Psychosomatics; 1981 Mar; 22(3):241-7. PubMed ID: 6111827
    [No Abstract]   [Full Text] [Related]  

  • 29. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.
    Anand R; Geffen Y; Vasile D; Dan I
    Clin Neuropharmacol; 2010; 33(6):297-302. PubMed ID: 20921890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptic-induced movement disorders: historical perspectives].
    Wolf MA; Yassa R; Llorca PM
    Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of idiopathic recurrent priapism with fluoxetine and low dose Perphenazine.
    Khazaie H; Moradi M; Tahmasian M; Ahmadi A
    J Pak Med Assoc; 2008 Mar; 58(3):142-3. PubMed ID: 18517121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 36. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 37. Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine.
    Simpson DM; Davis GC
    Am J Psychiatry; 1984 Jun; 141(6):796-7. PubMed ID: 6145359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Depot preparations in psychiatry].
    Gunby B
    Tidsskr Nor Laegeforen; 1974 Jan; 94(3):176-7. PubMed ID: 4150719
    [No Abstract]   [Full Text] [Related]  

  • 39. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.